JP2004535795A5 - - Google Patents

Download PDF

Info

Publication number
JP2004535795A5
JP2004535795A5 JP2002589630A JP2002589630A JP2004535795A5 JP 2004535795 A5 JP2004535795 A5 JP 2004535795A5 JP 2002589630 A JP2002589630 A JP 2002589630A JP 2002589630 A JP2002589630 A JP 2002589630A JP 2004535795 A5 JP2004535795 A5 JP 2004535795A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
nucleic acid
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002589630A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004535795A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/014587 external-priority patent/WO2002092762A2/en
Publication of JP2004535795A publication Critical patent/JP2004535795A/ja
Publication of JP2004535795A5 publication Critical patent/JP2004535795A5/ja
Withdrawn legal-status Critical Current

Links

JP2002589630A 2001-05-10 2002-05-08 サイトカインポリペプチド群 Withdrawn JP2004535795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29023901P 2001-05-10 2001-05-10
PCT/US2002/014587 WO2002092762A2 (en) 2001-05-10 2002-05-08 Cytokine polypeptides

Publications (2)

Publication Number Publication Date
JP2004535795A JP2004535795A (ja) 2004-12-02
JP2004535795A5 true JP2004535795A5 (enExample) 2005-12-22

Family

ID=23115104

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002589630A Withdrawn JP2004535795A (ja) 2001-05-10 2002-05-08 サイトカインポリペプチド群

Country Status (8)

Country Link
US (2) US20030104579A1 (enExample)
EP (1) EP1412499A4 (enExample)
JP (1) JP2004535795A (enExample)
AU (1) AU2002314774B2 (enExample)
CA (1) CA2446180A1 (enExample)
MX (1) MXPA03010181A (enExample)
PL (1) PL373008A1 (enExample)
WO (1) WO2002092762A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448993C (zh) 2000-06-30 2009-01-07 津莫吉尼蒂克斯公司 干扰素样蛋白质Zcyto21
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US7910313B2 (en) 2001-04-20 2011-03-22 Zymogenetics, Inc. Cytokine protein family
EP1942187B1 (en) * 2001-04-20 2010-09-22 ZymoGenetics, L.L.C. Cytokine protein family
WO2003066002A2 (en) 2002-02-08 2003-08-14 University Of Medicine And Dentistry Of New Jersey IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
AU2003286624B2 (en) 2002-10-23 2008-11-13 Bristol-Myers Squibb Company Methods for treating viral infection using IL-28 and IL-29
ES2303132T3 (es) 2003-08-07 2008-08-01 Zymogenetics, Inc. Preparaciones homogeneas de il-29.
JP4896005B2 (ja) 2004-04-02 2012-03-14 ザイモジェネティクス リミテッド ライアビリティ カンパニー Il−28およびil−29システイン変異体を用いるウイルス感染を治療するための方法
CA2574564C (en) * 2004-07-29 2013-04-16 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer and autoimmune disorders
US8158129B2 (en) * 2005-04-06 2012-04-17 Ibc Pharmaceuticals, Inc. Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのil28およびil29の短縮型システイン変異体の使用法
EP2922870B1 (en) * 2012-11-21 2019-08-07 The Governors of the University of Alberta Immunomodulatory peptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822082B2 (en) * 2000-06-30 2004-11-23 Zymogenetics, Inc. Polynucleotides for mammalian secreted protein, Z1055G2P
CN100448993C (zh) * 2000-06-30 2009-01-07 津莫吉尼蒂克斯公司 干扰素样蛋白质Zcyto21

Similar Documents

Publication Publication Date Title
JP2004535795A5 (enExample)
US12134656B2 (en) Dickkopf-1 variant antibodies and methods of use
KR101502179B1 (ko) 전사 부정확, 검출 및 이의 용도
JP2014509853A5 (enExample)
JP2005514901A5 (enExample)
JP2002502589A5 (enExample)
JP2008538183A5 (enExample)
JP2008525033A5 (enExample)
WO2016077366A1 (en) Therapeutic and diagnostic methods for il-33-mediated disorders
JP2005522999A5 (enExample)
DK1481990T3 (da) A33-beslægtede antigener og deres farmakologiske anvendelser
JP2004535161A5 (enExample)
JP2005511023A5 (enExample)
JP2004513614A5 (enExample)
JP2005507648A5 (enExample)
EP1944321A2 (en) Methods and compositions for determining the purity of chemically synthesized nucleic acids
JPH1066585A5 (enExample)
EP4667484A1 (en) Homodimeric protein combining human il-1r1 with human il-1racp polypeptide fragments and use
JP2004537284A5 (enExample)
CN109486824A (zh) 一种特异性结合Taq酶的核酸适配体及其筛选方法、应用
JP2003510078A5 (enExample)
JP2012153664A (ja) 抗il28b抗体及びこれを用いたil28bの測定方法
JP2008507253A5 (enExample)
JP2004065264A5 (enExample)
JP2004515215A5 (enExample)